Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Ранг среди акций #13762
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Цена акции
$0.85814713
Последняя синхронизация: 2025-05-14
Рыночная капитализация
$463.40M
Изменение (1 день)
-2.52%
Изменение (1 год)
0.00%
Страна
GB
Торговля Alliance Pharma plc (APH)

Категория

EPS для Alliance Pharma plc (APH)
EPS по состоянию на December 2024 TTM: $-0.03
Согласно последним финансовым отчетам и цене акций Alliance Pharma plc, текущий EPS компании (TTM) составляет $-0.03. В конце 2023 EPS компании составлял $-0.08, меньше, чем показателю 2022 года, равному $0.00.
История EPS компании Alliance Pharma plc с 2001 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $-0.03 -16.67%
2024 $-0.03 -67.95%
2023 $-0.08 -3,814.29%
2022 0.00 -88.65%
2021 $0.02 -12.32%
2020 $0.02 -66.88%
2019 $0.06 35.53%
2018 $0.05 -42.96%
2017 $0.08 73.47%
2016 $0.05 -30.66%
2015 $0.07 38.66%
2014 $0.05 -21.96%
2013 $0.06 8.02%
2012 $0.06 4.27%
2011 $0.06 -8.77%
2010 $0.06 60.42%
2009 $0.04 69.91%
2008 $0.02 -157.22%
2007 $-0.04 -726.98%
2006 $0.01 -18.18%
2005 $0.01 -116.96%
2004 $-0.05 109.22%
2002 $-0.02 -401.39%
2001 $0.01 0.00%
EPS для аналогичных компаний или конкурентов